New COVID-19 prediction models forecast a potential fourth wave and how to minimize it
February 23, 2021 at 12:00 pm
Underwritten by
This special series focuses on important community issues, innovative solutions to societal challenges, and people and non-profit groups making an impact through technology.
In a bootcamp that launched in January, University of Washington School of Nursing students train other UW students and faculty who hope to help in COVID-19 vaccinations. (Kiyomi Taguchi / University of Washington Photo)
Let’s start with the good news. The number of new COVID-19 cases in the greater Seattle area, Washington state and the national level have all been declining since early January, showing a recovery from what’s known as the third wave of infections.
Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell Transplantation, Treosulfan, in the United States
February 02, 2021 14:21 ET | Source: Medexus Pharmaceuticals Inc Medexus Pharmaceuticals Inc
Orphan Designated Drug with August 2021 PDUFA date
Management to host conference call at 10:00 AM Eastern Time on February 3, 2021 and
Key Opinion Leader webinar to be held at 2:00 PM Eastern Time on February 5, 2021
TORONTO and CHICAGO and MONTREAL and WEDEL, Germany, Feb. 02, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (“
Medexus”) (TSXV: MDP) (OTCQX: MEDXF)
(Frankfurt: P731) is pleased to announce that it and its wholly-owned United States-based subsidiary, Medexus Pharma, Inc. (“
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class .
Medexus Pharmaceuticals IncFebruary 2, 2021 GMT
Orphan Designated Drug with August 2021 PDUFA date
Management to host conference call at 10:00 AM Eastern Time on February 3, 2021 and
Key Opinion Leader webinar to be held at 2:00 PM Eastern Time on February 5, 2021
TORONTO and CHICAGO and MONTREAL and WEDEL, Germany, Feb. 02, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (“Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) is pleased to announce that it and its wholly-owned United States-based subsidiary, Medexus Pharma, Inc. (“Medexus Pharma” and together with Medexus, the “Company”) entered into a Commercialization and Supply Agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. (“medac”), pursuant to which medac has granted Medexus Pharma an excl
President
Curt Gimmestad, vice president of industry engagement at Absher Construction Co., started with the company as a project engineer in 1993. Gimmestad has served the AGC in many capacities, including first vice president in 2019, an association trustee, and an instructor and executive board member for the Education Foundation. He also is a member of the Association for Learning Environments and the Capital Advisory Review Board’s Project Review Committee.
Stephens
First Vice President
Dawn Stephens is the CFO of Charter Construction, where she oversees financial processes and operations. Her career as a finance professional spans more than 25 years at several construction and real estate firms. In 2006, Stephens joined Harbor Properties as corporate controller and later became CFO. She is active in Commercial Real Estate Women, is past president of the Puget Sound Chapter of the Construction Financial Managers Association, and serves on several committees benefitin